Novartis steps in to help seed a Michigan spinout’s move into the clinic with new eye drug
Novartis has joined hands with some local investors in Michigan to come up with a small but significant $4.25 million A round for a startup …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
